Question 1

What is CorMedix's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount?

Accepted Answer

CorMedix (CRMD) reported effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount of -$15.18M in Q4 2025.

Question 2

How has CorMedix's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount changed year-over-year?

Accepted Answer

CorMedix's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount decreased by 9094.5% year-over-year, from $168.75K to -$15.18M.

Question 3

What is the long-term trend for CorMedix's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount?

Accepted Answer

Over 4 years (2021 to 2025), CorMedix's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount has grown at a 91.2% compound annual growth rate (CAGR), from $4.54M to -$60.71M.

Question 4

What does effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount mean?

Accepted Answer

Measures the adjustment to the valuation allowance for deferred tax assets within the income tax reconciliation. A change here reflects management's assessment of the likelihood that deferred tax assets will be realized in future periods.

CorMedix CRMD Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount

Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

Ask your AI about CorMedix's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount.

Questions, answered.